Associate Professor Fraser trained at Sydney Eye Hospital, and did fellowships at Moorfields Eye Hospital (London, UK) and Emory Eye Center (Atlanta, USA). She has specialised in neuro-ophthalmology, strabismus and visual electrodiagnostics. She is a consultant Visiting Medical Officer at both Sydney Eye Hospital and Liverpool Hospital and is also in private practice in Sydney. At the University of Sydney, she holds the title of Associate Professor of Neuro-ophthalmology. Dr Fraser served as Vice President of The Neuro-Ophthalmology Society of Australia, is Chair of the North American Neuro-Ophthalmology Society International Committee and is on the committee for the Neuro-Ophthalmology Virtual Education Library and on the editorial boards for several high impact ophthalmology journals.
Professor Pozo-Rosich is a Head of Section in the Neurology Department at Vall d’Hebron University Hospital in Barcelona and Director of the Migraine Adaptive Brain Centre. Professor Pozo-Rosich is also Coordinator of the Brain, Mind & Behaviour eCORE and in charge of the Headache Research Laboratory at the Vall d’Hebron Institute of Research. Professor Pozo-Rosich is the Honorary Secretary of the International Headache Society and a Scientific Advisory Board member of the Lilly Foundation in Spain. She is the Editor for Headache for Revista de Neurologia, and Associate Editor of Cephalalgia, Headache, Neurologia, Frontiers in Neurology (Headache Medicine) and a member of the Editorial Advisory Board of The Journal of Headache and Pain.
Professor Mollan is Honorary Professor at the University of Birmingham and a Consultant Neuro-ophthalmologist at University Hospitals Birmingham (UHB), in the United Kingdom. She is the Director of Ophthalmology Research and the Data Officer for INSIGHT (a Health Data Research UK hub for eye health) at UHB. She is an International Senior Examiner for the Royal College of Ophthalmologists and an active committee member at the North American Neuro-Ophthalmology Society. She is a key opinion leader in IIH and was the lead author of the IIH consensus guidelines (2018); and the European Headache Federation IIH guidelines (2019).
Professor Danesh-Myer is Professor, Faculty of Medical and Health Sciences, Ophthalmology and holds the Sir William and Lady Stevenson Chair in Ophthalmology and Head of Academic Neuro-ophthalmology and Glaucoma, University of Auckland and Director of the Eye Institute. She heads the Optic Nerve Research Unit which is involved in translational research investigating the role of neuroinflammation in optic nerve and retinal injury. She is also recognized internationally for her pioneering work on the role of ocular imaging in neuro-ophthalmology. Professor Danesh-Meyer is an international authority in glaucoma and neuro-ophthalmology.
Professor Lagrèze is Professor of Ophthalmology at the University Medical Center Freiburg, Germany, where he holds the Chair of Neuro-ophthalmology and Pediatric Ophthalmology. He studied Medicine at the University of Frankfurt and did his MD thesis at the Max Planck-Institute for Brain Research, Frankfurt. Dr Lagrèze directs the Interdisciplinary Center for Orbital Diseases at the same institution and has a strong research interest in pediatric ophthalmology, neuro-ophthalmology and orbital diseases.
Thank you for your interest in the Invex Therapeutics IIH EVOLVE Phase III Clinical Study. To contact us please see our advice below:
This email address should be used by healthcare professionals either with an interest in or already working on Invex’s phase III IIH-EVOLVE clinical study. Please note that all information on ongoing clinical trials including eligibility criteria and contact information are posted on the https://clinicaltrials.gov/ website under ClinicalTrials.gov Identifier: NCT05347147.
For IIH patient enquiries:
Please do not send us any information regarding your condition.
Should you want to see if you could be eligible for our IIH-EVOLVE study you can find more information and contact suggestions at https://clinicaltrials.gov/ct2/show/NCT05347147
Alternatively, you could contact your healthcare provider or find more information regarding your condition from patient organisations in your country of residence, for example:
For General Corporate or Investor enquiries:
This email address is for all queries regarding Corporate or Investor matters only.